Indaptus Therapeutics, Inc. (INDP) Insider Trading Disclosures
Indaptus Therapeutics, Inc. (INDP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INDP
CIK: 1857044
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerDavid Brownstein
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-8 | 2026-10-05 | — | S-8 | 0001493152-26-045746 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-29 | 8-K | 0001493152-26-045040 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-08 | 8-K | 0001493152-26-042037 | View SEC Doc Filr Page |
| 8-K/A | 2026-09-08 | 2026-08-28 | 8-K/A | 0001493152-26-041636 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-09-02 | 8-K | 0001493152-26-041532 | View SEC Doc Filr Page |
| 424B5 | 2026-09-04 | — | 424B5 | 0001493152-26-041526 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-28 | 8-K | 0001493152-26-040926 | View SEC Doc Filr Page |
| 424B5 | 2026-08-31 | — | 424B5 | 0001493152-26-040751 | View SEC Doc Filr Page |
| 424B3 | 2026-08-26 | — | 424B3 | 0001493152-26-040246 | View SEC Doc Filr Page |
| EFFECT | 2026-08-25 | — | EFFECT Filing | 9999999995-26-002761 | View SEC Doc Filr Page |
| S-3 | 2026-08-17 | — | S-3 | 0001493152-26-038780 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037579 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-10 | 8-K | 0001493152-26-037574 | View SEC Doc Filr Page |
| EFFECT | 2026-07-17 | — | EFFECT Filing | 9999999995-26-002348 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-16 | 2026-07-16 | DEF 14A | 0001493152-26-033545 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-26 | — | SCHEDULE 13D/A Filing | 0001829126-26-006953 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-26 | — | SCHEDULE 13D/A Filing | 0001829126-26-006951 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-26 | — | SCHEDULE 13D/A Filing | 0001829126-26-006950 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-26 | — | SCHEDULE 13D/A Filing | 0001829126-26-006949 | View SEC Doc Filr Page |
| S-3 | 2026-06-26 | — | S-3 | 0001493152-26-030346 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-17 | 8-K | 0001493152-26-029918 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-22 | 2026-06-22 | PRE 14A | 0001493152-26-029633 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-01 | 8-K | 0001493152-26-027499 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023362 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001493152-26-023344 | View SEC Doc Filr Page |